Delivery Order SPE2DB24D1021-SPE2DB25FEZHC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency (DLA) awarded a $11,854.88 delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. This firm fixed-price delivery order, issued on December 6, 2024, with an ultimate completion date of December 9, 2024, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $83,574.45 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a specialized medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,784.51 Firm Fixed Price Delivery Order is for the supply of 4567602337 - ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, with a ceiling value of $17,807.88. This firm fixed-price contract was competitively awarded without set-aside designation and has an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,864.71 firm fixed price delivery order contract to provide ACTIVASE 50 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $43,423.53 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,240,989 units of ACTIVASE 100 MG VIALS. This order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,472.68 firm fixed-price delivery order is for the supply of 100 mg ACTIVASE vials, a medication used for the treatment of certain medical conditions. The contract has a completion date of November 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $3,200 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561599079 units of ACTIVASE 50 MG VIALS to be delivered to a location in Conshohocken, Pennsylvania by July 26, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger governmentwide acquisition contract. The prime...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $34,134.85 contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a completion date of January 16, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader work providing pharmaceuticals, medical supplies, and distribution...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZHCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ACTIVASE 50 mg vials, valued at $8,903.91, with a firm fixed price arrangement. This contract, issued on August 5, 2025, represents a direct fulfillment order with an ultimate completion date of August 6, 2025. The award was not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse medical commodities including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for ACTIVASE 50 mg vials—a thrombolytic medication used in acute medical situations—exemplifies the company's role as a prime vendor for time-sensitive pharmaceutical needs within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 8/5/25 |